Johannes Andel

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

2016 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication